| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| PSGL-1 | Human PSGL-1 / CD162 Protein, His Tag | Human | HEK293 | ![]() | SDS-PAGE | $395.00 100ug | |||
| PSGL-1 | Avitag PS1-H82E4 | Biotinylated Human PSGL-1 / CD162 Protein, His,Avitag™ | Human | HEK293 | ![]() | SDS-PAGE | $360.00 25ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Cepeprubart | SelK-2 | Phase 2 Clinical | Selexys | Asthma; Pulmonary Disease, Chronic Obstructive; Venous Thromboembolism | Details |
| Leiolizumab | AbGn 168H2; AbGn-268; AbGn-168H2; ALTB-268 | Phase 2 Clinical | Altrubio Inc | Arthritis, Psoriatic; Colitis, Ulcerative | Details |
| Neihulizumab | AbGn-168; AbGn-168H; ALTB-168 | Phase 1 Clinical | Altrubio Inc | Arthritis, Psoriatic; Colitis, Ulcerative; Graft vs Host Disease; Plaque psoriasis; Psoriasis | Details |
| SSGJ-617 | SSGJ-617; SSGJ617; 61X; VTX-0811; 617 | Phase 1 Clinical | Verseau Therapeutics Inc | Solid tumours | Details |